Results overview: Found 1 records in 0.02 seconds.
Articles, 1 records found
Articles 1 records found  
1.
8 p, 500.4 KB Dynamic molecular analysis and clinical correlates of tumor evolution within a phase II trial of panitumumab-based therapy in metastatic colorectal cancer / Siena, S. (Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy) ; Sartore-Bianchi, A. (Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy) ; García-Carbonero, Rocío (Universidad Complutense de Madrid) ; Karthaus, M. (Department for Hematology and Oncology, Staedt Klinikum Neuperlach and Harlaching, Munich, Germany) ; Smith, D. (Bordeaux University Hospital (França)) ; Tabernero, Josep (Universitat Autònoma de Barcelona) ; Van Cutsem, E. (KU Leuven, Leuven, Belgium) ; Guan, X (Amgen Inc., Thousand Oaks, CA, USA) ; Boedigheimer, M. (Amgen Inc., Thousand Oaks, CA, USA) ; Ang, A. (Amgen Inc., Thousand Oaks, CA, USA) ; Twomey, B. (Amgen Inc., Thousand Oaks, CA, USA) ; Bach, B. A. (Amgen Inc., Thousand Oaks, CA, USA) ; Jung, A. S. (Amgen Inc., Thousand Oaks, CA, USA) ; Bardelli, Alberto (Department of Oncology, University of Torino, Candiolo, Italy)
Mutations in rat sarcoma (RAS) genes may be a mechanism of secondary resistance in epidermal growth factor receptor inhibitor-treated patients. Tumor-tissue biopsy testing has been the standard for evaluating mutational status; however, plasma testing of cell-free DNA has been shown to be a more sensitive method for detecting clonal evolution. [...]
2017 - 10.1093/annonc/mdx504
Annals of oncology, Vol. 29 (september 2017) , p. 119-126  

See also: similar author names
1 Twomey, B.
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.